Your search for tofacitinib returned 1 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Alerts remove
Lea Eslava-Kim, PharmD remove
Older than 2 years remove
Home remove

Your search for tofacitinib returned 1 results

Sort Results:

Relevant Recent

Pfizer announced top-line results from its first Phase 3 study, OPAL Broaden, evaluating the efficacy and safety of tofacitinib for the treatment of active psoriatic arthritis (PsA) in adults who had an inadequate response to at least one conventional synthetic disease-modifying antirheumatic drug (csDMARD) and who were tumor necrosis factor inhibitor (TNFi)-naïve.